GSK plans 60 job cuts at Quebec vaccine plant

GlaxoSmithKline ($GSK) plans to cut 9% of its Quebec City workforce, with most of the cuts coming at a vaccines plant that produces seasonal flu shots. About 60 jobs are expected to be affected by the move. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.